# Effects of Medications in Patients With Hypogonadism

> **NCT01601327** · PHASE4 · COMPLETED · sponsor: **Gulhane School of Medicine** · enrollment: 119 (actual)

## Conditions studied

- Idiopathic Hypogonadotropic Hypogonadism

## Interventions

- **DRUG:** Testosterone enanthate (Sustanon 250 mg)
- **DRUG:** Human chorionic gonadotropin (hCG) (Pregnyl 5000 IU)
- **DRUG:** Testosteron gel (Testojel 50 mg)

## Key facts

- **NCT ID:** NCT01601327
- **Lead sponsor:** Gulhane School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2012-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01601327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01601327, "Effects of Medications in Patients With Hypogonadism". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01601327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*